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are interdependent (see for example Niemann et al., 2005; Graier 
et al., 2007; Gunter and Sheu, 2009 see also below). Experimental 
results obtained using drugs or mutations that interfere with one 
aspect of mitochondrial physiology thus need to be interpreted 
with care, as they may have numerous side effects.
This review focuses on the role of presynaptic mitochondria 
in the control of synaptic vesicle (SV) function. In general, SVs 
can be attributed to three functionally different pools, termed the 
readily releasable pool, the recycling pool and the reserve pool (RP) 
(Rizzoli and Betz, 2005). Together, the readily releasable pool and 
the recycling pool, sometimes referred to as the exo-endo cycling 
pool (ECP), typically represent about 10–20% of the SVs and are 
released under moderate or intense neuronal activity, whereas vesi-
cles from the RP are recruited only upon high frequency stimulation 
(Figure 2) (Kuromi and Kidokoro, 2005; Rizzoli and Betz, 2005). 
Based on these characteristics, different stimulation protocols have 
been developed that allow the specific mobilization of SVs from dif-
ferent pools as well as their labeling with fluorescent dyes (Kuromi 
and Kidokoro, 2002; Verstreken et al., 2008). Because the synaptic 
vesicle cycle involves numerous ATP-consuming steps and is tightly 
controlled by the cytosolic calcium concentration ([Ca2+]cyto), vesicle 
cycling appears to be highly dependent on mitochondrial function. 
In the following sections we will review recent reports indicating 
how mitochondria can affect the distribution in pools and release 
properties of SVs. In particular, we reexamine experimental evi-
dence which together indicate that these organelles are essential 
for synaptic vesicle release under conditions of intense neuronal 
activity through vesicle mobilization from the RP. Current stud-
ies dedicated to this link between mitochondria and the SV cycle 
IntroductIon
Mitochondria are energy-generating organelles found in virtually 
all eukaryotic cell types. They are strikingly abundant in neurons 
and in particular at chemical synapses (Palay, 1956) where neuronal 
communication takes place. It has long been recognized that mito-
chondria are important for the maintenance of neuronal integrity 
and function, as diseases caused by a mitochondrial failure often 
display a neurodegenerative component affecting the central or 
peripheral nervous system (DiMauro and Schon, 2008). Conversely, 
mitochondrial defects are frequently observed in tissue samples col-
lected from patients with a neurodegenerative disorder (Chen and 
Chan, 2009) and the involvement of mitochondrial dysfunction in 
a large number of diseases likely remains gravely underestimated 
(Table 1). These observations suggest an intimate involvement of 
mitochondria in maintaining neuronal integrity, possibly in part 
by controlling neurotransmission, yet the exact function of these 
organelles in synaptic activity has long remained elusive.
Mitochondria are dynamic organelles that divide, fuse and are 
redistributed within the cell in response to various physiologi-
cal cues. Besides their predominant role in energy metabolism 
(Figure 1), they are involved in many other cellular processes that 
are also relevant for neuronal function, including the regulation 
of calcium homeostasis and a form of programmed cell death (or 
apoptosis). Defects in all these functions as well as in mitochondrial 
fusion or fission are predicted to affect various aspects of neuronal 
physiology (DiMauro and Schon, 2008; Chen and Chan, 2009). 
However, unraveling the link between a mitochondrial defect and 
its consequences on neuronal function or survival has proven a 
complex task, mostly because different mitochondrial functions 
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will hopefully lead to new therapeutic strategies for the   handling 
of neurological disorders characterized by a mitochondrial defect 
and  which  have  a  tremendous  social  impact,  like Alzheimer’s, 
Huntington’s and Parkinson’s diseases.
calcIum bufferIng by presynaptIc mItochondrIa 
Influences exo- and endocytosIs of sVs
In excitable cells, depolarization of the plasma membrane triggers 
the opening of voltage-gated calcium channels, leading to Ca2+ entry 
and a subsequent rise of the [Ca2+]cyto that initiates various down-
stream cellular responses. In neurons, calcium signaling is involved 
in neurotransmitter release from the presynaptic terminals, in vesicle 
recycling via endocytosis and in long-term neuronal responses like 
neurite growth and degeneration, or modulation of synaptic strength 
(Ghosh and Greenberg, 1995; Zucker, 1999; Jonas, 2006; Yao et al., 
2009). Similarly to the endoplasmic reticulum (ER), mitochondria are 
able to sequester and release Ca2+ ions and thereby modulate calcium-
dependent signaling events. Finally, mitochondria may also contribute 
to calcium homeostasis by providing ATP to fuel the plasma mem-
brane Ca2+-ATPase (Zenisek and Matthews, 2000). Considerable effort 
has thus been invested in studying how presynaptic mitochondria 
control the time-course and the amplitude of calcium signaling.
Mitochondrial calcium uptake is driven by the negative potential 
established across the inner mitochondrial membrane (Figure 1) 
and can be inhibited by drugs that dissipate the proton gradient 
responsible for this potential (Gunter et al., 2000; Graier et al., 
2007). The outer mitochondrial membrane is relatively perme-
able to calcium ions, so that Ca2+ accumulation in the mitochon-
drial matrix mainly depends on a mitochondrial calcium uniporter 
(MCU) that resides in the inner membrane (Figure 1). The MCU 
shows a very low affinity for calcium ions (Km estimated between 1 
and 189 μM in different mitochondrial preparations) (Gunter and 
Sheu, 2009), that can be overcome by the proximity between mito-
chondria and the Ca2+ source, i.e., the cytosolic orifice of calcium 
channels at the mitochondria-ER (see below) or mitochondria-
plasma membrane contact sites, where local subdomains of high 
Ca2+ concentration can be generated (Rizzuto et al., 1999; Montero 
et al., 2000). In heart and liver cells, an additional calcium uptake 
mechanism that does not rely on the MCU, termed rapid uptake 
mode, has also been described (Buntinas et al., 2001). Once accu-
mulated in the matrix, calcium ions can be buffered by forming 
reversible Ca2+-phosphate complexes, or be exported back to the 
cytosol by a Na+/Ca2+ exchanger (Figure 1) (Gunter and Sheu, 2009). 
Interestingly, mitochondrial transport along microtubule tracks is 
negatively regulated by calcium (Yi et al., 2004) (see also below), 
and in Drosophila Ca2+ ions were found to disrupt the interaction 
between the motor protein kinesin and the Miro GTPase, which is 
required for the transport of these organelles along microtubules 
(Figure 1) (MacAskill et al., 2009). Local subcellular regions of 
elevated [Ca2+]cyto building up during the opening of voltage-gated 
Table 1 | Neurological and psychiatric disorders associated with mitochondrial dysfunction.




Affecting sensory and motorneurons 
of the distal extremetities
Mitofusin 2 Fusion (Chen and Chan, 2005, 2009)
Autosomal dominant 
optic atrophy (DOA)
Degeneration of retinal ganglia cells 
which leads to optic nerve atrophy
OPA1 Fusion (Chen and Chan, 2005, 2009)
Parkinson’s disease Degeneration of dopaminergic 
neurons in the substantia nigra
Pinkl, DJ-1, Parkin Electron transport chain, oxidative stress, 
mitophagy (Kahle et al., 2009; Morais et al., 
2009; Tanaka, 2010)
Huntington’s disease Progressive loss of striatal and cortical 
neurons
Huntingtin Electron transport chain, Ca2+ storage (Petrozzi 
et al., 2007; Bossy-Wetzel et al., 2008)
Alzheimer’s disease Neuronal death in cerebral cortex APP , Presenilin Fusion/fission (Wang et al., 2009)
Amyotrophic lateral 
sclerosis
Degeneration of anterior horn cells of 
the spinal chord and cortical 
motorneurons
SOD1 Oxidative phosphorylation (Petrozzi et al., 2007)
Leigh’s Syndrome Necrotizing encephalopathy A broad variety of genes   Multiple complexes of the electron transport 
chain (Finsterer, 2008)
Multiple sclerosis Demyelination, neuroaxonal depletion A broad variety of genes  Multiple complexes of the electron transport 
chain (Kalman et al., 2007)
PSyChiaTriC DiSorDer
Autism Behavioural syndrome A broad variety of genes  Electron transport chain (Correia et al., 2006)
Schizophrenia Disorder of thought DISC1 Oxidative phosphorylation, splicing isoforms 
targeted to mitochondria (Shao et al., 2008; 
Ben-Shachar, 2009)
ChroNiCal NeuroloGiCal DiSorDer
Epilepsy Recurrent seizures A broad variety of genes  Oxidative phosphorylation  (Kudin et al., 2009)
Disorders are listed in this table along with their most characteristic phenotype, when known, their causative gene(s) and the mitochondrial features reported to be 
defective. The mitochondrial defect might be the direct cause of the disease or the result of an upstream dysfunction in the pathology.Frontiers in Synaptic Neuroscience  www.frontiersin.org  September 2010  | Volume 2  | Article 139  |  3
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affects neurotransmission, as synaptic depression is more rapid 
(David and Barrett, 2003) and under these conditions recovery 
from synaptic depression after a stimulus train is slowed down 
(Billups and Forsythe, 2002), suggesting that the prolonged pres-
ence of free calcium ions in the cytosol stimulates the depletion of 
the pool of available SVs. A first effect of mitochondrial calcium 
uptake is thus to restrict the period of neurotransmitter release after 
the arrival of an action potential at the nerve terminal.
Stimulation of SV exocytosis by cytosolic calcium ions is also at 
the heart of the so-called “residual calcium hypothesis”, according 
to which residual calcium ions present in the cytoplasm during the 
decay of the [Ca2+]cyto peak after each action potential increase the 
probability of neurotransmitter release (Katz and Miledi, 1968). 
Consistently, slow Ca2+ release from intracellular stores – i.e., the 
ER and/or mitochondria – after the stimulus end causes a persistent 
elevation of [Ca2+]cyto that in turn stimulates SV exocytosis (Tang 
and Zucker, 1997; Yang et al., 2003). This has been well described 
at the crayfish NMJ, where inhibition of mitochondrial Ca2+ uptake 
leads to a higher [Ca2+]cyto during tetanic stimulation, as in the work 
plasma membrane Ca2+ channel – as observed upon arrival of an 
action potential at the nerve terminal – might thus cause mito-
chondria to pause and transiently accumulate close to active zones 
where SVs will fuse.
In neurons, [Ca2+]cyto peaks stimulate SV exocytosis and hence 
neurotransmitter release. This effect is mediated by synaptotagmin, 
a Ca2+ sensor that resides in the vesicle membrane and promotes 
SNARE-mediated fusion with the presynaptic membrane (Tucker 
et al., 2004; Chicka et al., 2008).
By sequestering Ca2+, presynaptic mitochondria can rapidly 
buffer the [Ca2+]cyto and thus diminish the SV release probability, 
thereby accelerating recovery of neurotransmission after nerve 
stimulation. This role of mitochondria in Ca2+ buffering is promi-
nent in chromaffin cells (Montero et al., 2000) and in certain 
types of synapses, for example at the rat calyx of Held (Billups 
and Forsythe, 2002) and at the mouse neuromuscular junction 
(NMJ) (David and Barrett, 2003). In these synapses, pharmacologi-
cal inhibition of mitochondrial Ca2+ uptake slows down the decay 
of the [Ca2+]cyto peak observed after nerve stimulation. This in turn 
FiGure 1 | Mitochondrial functions susceptible to affect 
neurotransmission. Schematic representation of a mitochondrion illustrating 
the different mitochondrial functions discussed in the text. (1) Mitochondria are 
dynamic organelles, able to move bidirectionally along microtubules tracts with 
the help of motor proteins (kinesin for anterograde and dynein for retrograde 
axonal transport, respectively) and adaptor proteins (e.g., Milton and the 
associated Rho-GTPase Miro or syntabulin). Short-distance transport along actin 
filaments is mediated by myosin motors (not shown). (2) The Krebs cycle takes 
place in the mitochondrial matrix, generating α-ketoglutarate and electron 
donors (NADH and succinate). (3) Transamination of α-ketoglutarate yields the 
neurotransmitter glutamate, which can also be formed by glutamine hydrolysis. 
Glutamate can be further decarboxylated to yield GABA, another 
neurotransmitter. (4) The electron transport chain (ETC), consisting of 4 
multiprotein complexes, mediates electron transfer (blue arrow) from NADH and 
succinate to the electron acceptor O2. Numerous drugs target components of 
the ETC, for example MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and 
rotenone affect complex I while antimycin A1 inhibits complex III. Electron 
transfer is coupled with proton extrusion out of the matrix toward the 
intermembrane space, producing an electrochemical gradient across the inner 
membrane (about – 200 mV). (5) Protons ultimately return to the matrix through 
the ATP synthase, using the free energy produced by the ETC to drive ATP 
synthesis. Oligomycin is an inhibitor of the ATP synthase. (6) Mitochondria are 
also involved in calcium homeostasis, and Ca2+ ions can be sequestered in the 
matrix under the form of a reversible phosphate complex. While the outer 
mitochondrial membrane is rather permeable to calcium, Ca2+ entry across the 
inner mitochondrial membrane is mediated by a uniporter, and its extrusion 
largely relies on a sodium/calcium exchanger. Mitochondrial calcium transport 
can be inhibited by TPP+ (tetraphenylphosphonium).Frontiers in Synaptic Neuroscience  www.frontiersin.org  September 2010  | Volume 2  | Article 139  |  4
Vos et al.  Synaptic mitochondria and vesicle pools
Notably,  deregulated  mitochondrial  Ca2+  uptake  can  have 
deleterious consequences for neurons. When mitochondria are 
overloaded  with  Ca2+,  they  undergo  a  dramatic  event  termed 
mitochondrial permeability transition (MPT), i.e., the formation 
of non-selective pores in the inner mitochondrial membrane that 
allows the entry of any molecule smaller than 1,500 Dalton into 
the mitochondrial matrix, causing an increase in osmotic pres-
sure leading to mitochondrial swelling and rupture of the outer 
mitochondrial membrane (Norenberg and Rao, 2007). Strikingly, 
synaptic mitochondria are able to buffer less Ca2+ ions and are more 
prone to display MPT than non-synaptic mitochondria isolated 
from the same sample of rat cortical brain tissue (Brown et al., 2006) 
or mouse sympathetic neurons (Núñez et al., 2007). The reason 
for this difference in Ca2+-handling capacity remains unclear, but 
it might favor Ca2+-dependent exocytosis at the presynaptic sites by 
maintaining a higher [Ca2+]cyto. Yet a reduced Ca2+-buffering capac-
ity of synaptic mitochondria, caused under pathogenic conditions 
or by aging, may presumably increase their susceptibility to MPT 
and subsequent release of cell-death molecules (see below), leading 
to synapse degeneration as observed e.g., in Alzheimer’s disease 
(Selkoe, 2002), schizophrenia (Glantz et al., 2006) or Huntington’s 
disease (Damiano et al., 2010).
In some synapses like e.g., the Drosophila NMJ mitochondrial 
contribution to Ca2+ buffering appears to be only minor and/or 
easily compensated by alternative mechanisms, at least during mild 
stimulation (Guo et al., 2005; Verstreken et al., 2005; Lnenicka et al., 
2006). Inhibiting mitochondrial Ca2+ uptake in fly motor nerve 
terminals by adding TPP+ (tetraphenylphosphonium) (Verstreken 
et al., 2005) or antimycin A1 (Lnenicka et al., 2006) (Figure 1) does 
indeed not significantly influence calcium clearance or SV mobili-
zation and recycling after a 10 Hz train stimulus. In contrast, decay 
of the [Ca2+]cyto peak is significantly slowed down when the Ca2+ 
ATPase mediating calcium uptake into the ER is pharmacologically 
blocked or, to an even greater extent, when the plasma membrane 
Ca2+ ATPase (PMCA) is inhibited (Lnenicka et al., 2006). Although 
Ca2+ clearance is thus mainly ensured by the PMCA (Lnenicka et al., 
2006), calcium storage in the ER lumen contributes to evoked neu-
rotransmitter release at the Drosophila NMJ, supposedly by allowing 
the [Ca2+]cyto to remain elevated after the stimulus end (Sanyal et al., 
2005). Similarly, in frog motor nerve terminals intracellular Ca2+ 
release from the ER after cessation of stimulation leads to post-
tetanic potentiation (PTP) (Narita et al., 2000). In this context, it 
is worth noting that a very close physical connection between the 
ER and mitochondria can be observed in many cell types, including 
neurons (Mironov and Symonchuk, 2006). Such contacts, termed 
mitochondria-associated ER membrane (MAM), allow the bidi-
rectional exchange of phospholipids and Ca2+ ions between these 
organelles (Hayashi et al., 2009b; Kornmann et al., 2009; Rizzutto 
et al., 2009). In mouse respiratory neurons, where both the ER and 
mitochondria contribute to calcium-dependent modulation of syn-
aptic activity, some of the Ca2+ ions transiently accumulated within 
ER vesicles in response to a stimulus are subsequently transferred 
to the mitochondrial matrix (Mironov and Symonchuk, 2006). 
If this transfer is prevented, the peak of [Ca2+]mito observed after 
stimulation is smaller compared to controls and neurotransmitter 
release is reduced (Mironov and Symonchuk, 2006). Given the low 
affinity of the mitochondrial calcium uptake system, MAMs may 
from the groups of Forsythe and Barrett described above, and 
increases short-term augmentation (Tang and Zucker, 1997). In 
contrast, decay of the [Ca2+]cyto peak after tetanus is faster than in 
untreated neurons, thereby reducing long-term potentiation (Tang 
and Zucker, 1997). Recently, the importance of mitochondria in 
controlling presynaptic [Ca2+]cyto and hence in synaptic plasticity 
has been illustrated in mammals as well. Defective calcium buffer-
ing at mouse hippocampal presynaptic terminals, resulting from a 
lack of the microtubule-binding protein syntaphilin required for 
axonal docking of mitochondria (Figure 1), was shown to cause 
an elevation of [Ca2+]cyto during intense stimulation, prolonging 
the facilitation phenomenon observed in control neurons (Kang 
et al., 2008). In short, a second consequence of calcium buffering 
by mitochondria is that neurotransmitter release can be prolonged 
after the stimulus end as Ca2+ ions are progressively unloaded from 
the mitochondrial matrix into the cytosol.
There are thus both a negative and a positive effect of mito-
chondrial calcium sequestration on synaptic activity. According 
to the residual calcium hypothesis, a defect in calcium buffering is 
expected to favor recovery from depression, as indeed observed by 
several groups (Dittman and Regehr, 1998; Wang and Kaczmarek, 
1998). This however contrasts with the results from the groups of 
Barrett and Forsythe discussed above, according to which mito-
chondrial calcium buffering shortens synaptic depression (Billups 
and Forsythe, 2002; David and Barrett, 2003). This apparent dis-
crepancy is most likely due to the use of different stimulation pro-
tocols in various model systems, and to the different approaches 
used to observe calcium buffering, either via mobile calcium buffers 
(Dittman and Regehr, 1998; Wang and Kaczmarek, 1998) or spe-
cifically by the mitochondria (Billups and Forsythe, 2002; David 
and Barrett, 2003).
More importantly, this controversy also stresses the versatile 
role of calcium in the SV cycle. Indeed, Ca2+ ions not only influence 
exocytosis of SVs but also their recycling via endocytosis (Yao et al., 
2009). The [Ca2+]cyto required for proper endocytosis at synapses is 
much lower than the concentration needed to cause SV exocyto-
sis and is actually close to the intra-axonal [Ca2+]cyto (Shupliakov, 
2009), but there is a positive correlation between the intracellular 
calcium concentration and the endocytic rate (Wu et al., 2009). 
Experimental data collected e.g., from the frog NMJ (Ceccarelli 
and Hurlbut, 1980), giant lamprey synapse (Gad et al., 1998) and 
rat hippocampal neurons (Balaji et al., 2008) suggest that extracel-
lular Ca2+ might actually be required only to increase the endocytic 
capacity of the presynaptic membrane under conditions of intense 
stimulation, in order to compensate the large influx of exocytic 
material (Dittman and Ryan, 2009). The molecular mechanism of 
this regulation is only starting to be elucidated, but it appears that 
the calcium-binding protein calmodulin initiates endocytosis at 
the synapse and facilitates both plasma membrane invagination 
and fission (Wu et al., 2009). Moreover, other Ca2+-binding endo-
cytic proteins including synaptotagmin and endophilin have been 
identified (Brose et al., 1992; Chen et al., 2003). In conclusion, the 
overall effect of Ca2+ ions on neurotransmitter release should thus 
be regarded as a balance between the stimulation of SV exocytosis, 
which can promote either recovery from depression or SV depletion 
depending on the experimental conditions, and a positive effect 
on SV recycling.Frontiers in Synaptic Neuroscience  www.frontiersin.org  September 2010  | Volume 2  | Article 139  |  5
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1979) (Figure 1), and mitochondria with a high potential tend to 
accumulate at synapses (Lee and Peng, 2006). Finally, there appears 
to be a direct relationship between the frequency and/or the inten-
sity of activity in a given synapse and the number and metabolic 
activity of presynaptic mitochondria, both under physiological and 
pathological conditions (Atwood et al., 1986; Nguyen et al., 1997; 
Brodin et al., 1999; Dubinsky, 2009). All these observations point 
to a central role of mitochondrial ATP production in neuronal 
transmission, but the exact molecular mechanisms involved in this 
regulation are only beginning to be deciphered.
The number of presynaptic mitochondria is partially regulated 
by DRP1 (dynamin related protein) (Verstreken et al., 2005). This 
protein mediates mitochondrial fission (Praefcke and McMahon, 
2004; Rube and van der Bliek, 2004) and its activity is controlled 
by calcineurin, a Ca2+ responsive phosphatase (Cereghetti et al., 
2008). High Ca2+ leads to calcineurin activation (Guerini, 1997) 
and in turn to dephosphorylation and activation of DRP1 and thus 
mitochondrial fission, which has been associated with the transport 
of mitochondria into the synapse (Verstreken et al., 2005; Cereghetti 
et al., 2008) (Figure 2). Taken together, these data support a model 
thus play a critical role in the capacity of mitochondria to promptly 
respond to a change in [Ca2+]cyto and thereby affect many aspects 
of mitochondrial biology (Hayashi et al., 2009b), including the 
control of SV exocytosis and/or endocytosis.
Finally, in addition to their direct effects on exocytosis and endo-
cytosis, Ca2+ ions can also regulate the SV cycle indirectly by modu-
lating mitochondrial bioenergetics. Three enzymes of the Krebs 
cycle residing in the mitochondrial matrix are indeed activated in a 
calcium-dependent manner (Duchen, 1992), so that mitochondrial 
calcium uptake increases the flux of electrons through the elec-
tron transport chain (ETC) and hence ATP production (Figure 1) 
(Graier et al., 2007; Gunter and Sheu, 2009). As a consequence, 
drugs preventing mitochondrial calcium uptake also negatively 
affect ATP production, thereby complicating the interpretation 
of experimental data. Thus it is advisable to look at the effects 
of these drugs under conditions where the cytosolic ATP level is 
artificially preserved.
In conclusion, Ca2+ ions play a versatile role in several steps of the 
SV cycle through different Ca2+ sensors. Mitochondria thus affect 
exocytosis and endocytosis of SVs through their ability to regulate 
Ca2+ homeostasis. However, the relative contribution of the ER and 
mitochondria to synaptic Ca2+-buffering appears to vary between 
different neuronal systems and might be influenced by the integra-
tion of different signaling pathways (Rizzuto, 2003).
mItochondrIal atp productIon Is requIred for sV 
mobIlIzatIon and recyclIng under Intense 
stImulatIon
The most well-known function of mitochondria is to produce energy, 
and in neurons they generate the majority of ATP (about 90 %) via 
aerobic metabolism (Figure 1), the rest being provided by glycolysis 
in the cytosol (Mathews and Van Holde, 1995). This energy supply is 
critical since proper neuronal function requires ATP in order to fuel 
ion pumps, to organize cytoskeletal components, to support numer-
ous phosphorylation reactions (Attwell and Laughlin, 2001) and 
for many steps in the SV cycle including myosin-dependent axonal 
transport of SVs, their SNARE-mediated fusion with the plasma 
membrane, membrane scission, vesicle uncoating and refilling of 
vesicles with neurotransmitter (Murthy and Camilli, 2003).
Because of the highly specialized architecture of neurons, with 
their long processes contacting cells located far away from the 
cell body, ATP diffusion from a central location to the distal syn-
apses is thought to be too slow to meet these energy requirements 
(Kuiper et al., 2008). Accordingly, in neurons mitochondrial bio-
genesis occurs mostly in the soma (Davis and Clayton, 1996) but 
these organelles can subsequently be transported along cytoskel-
eton tracks in the neuronal processes (Figure 1) (Hollenbeck and 
Saxton, 2005), where they show saltatory bidirectional movement, 
with frequent pauses and changes of direction (Cai and Sheng, 
2009). Mitochondria are then specifically retained in regions of 
the axon where the energy demand is high (Hollenbeck, 2005), 
including synapses (Palay, 1956; Nguyen et al., 1997) and in par-
ticular near the active zones where SVs are released (Rowland et al., 
2000; Perkins et al., 2010). Moreover, there is a positive correla-
tion between anterograde axonal transport of mitochondria and 
the electrical potential across their inner membrane (Miller and 
Sheetz, 2004) which drives ATP production (Alfonzo and Racker, 
FiGure 2 | Schematic representation of a mitochondrial involvement in 
the organization of synaptic vesicle pools. (1) Synaptic vesicles (SVs) from 
the exo-endo cycling pool (ECP) participate in neurotransmitter release at 
active zones (in red). Upon arrival of an action potential at the nerve terminal, 
these vesicles fuse with the presynaptic membrane and discharge 
neurotransmitters in the synaptic cleft. (2) In contrast, SVs from the reserve 
pool (RP), which contains the majority of vesicles in most synapses, are 
tethered to cytoskeletal elements and are only recruited to the active zone 
during intense stimulation. This recruitment of the RP depends on ATP 
produced by the mitochondria. (3) The ATP produced by the mitochondria also 
plays an important role for preynaptic Ca2+ buffering in the endoplasmic 
reticulum (ER). High Ca2+, induced by exo-endocytosis, activate calcineurin 
that in turn activates and dephosphorylates DRP1, resulting in mitochondrial 
fission and transport.Frontiers in Synaptic Neuroscience  www.frontiersin.org  September 2010  | Volume 2  | Article 139  |  6
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similar dependence of neurotransmission on mitochondrial ATP 
production has recently been observed in mammalian neurons, 
where anterograde transport of mitochondria along the axon relies 
on the adaptor protein syntabulin, linking these organelles to the 
kinesin heavy chain (Figure 1) (Cai et al., 2005). Knock-down of 
syntabulin or disruption of its interaction with kinesin impair neu-
rotransmitter release under intense stimulation conditions and this 
defect is partially rescued by exogenous ATP addition (Ma et al., 
2009), paralleling the effects of the fly drp1 mutation (Verstreken 
et al., 2005).
Interestingly, in rat hippocampal neurons the GTPase activity 
of Drp1 appears to be positively regulated by the antiapoptotic 
protein Bcl-xL (Li et al., 2008). By activating Drp1, Bcl-xL promotes 
mitochondrial fission and recruitment at developing synaptic sites, 
and is believed to thereby increase ATP availability to fuel synap-
togenesis and further synaptic activity (Jonas et al., 2003; Li et al., 
2008). Overexpression of either Bcl-xL or Drp1 in rat hippocampal 
neurons leads to the formation of larger SV clusters compared 
to controls. Conceivably, the presence of an increased number of 
mitochondria at the synapses may stimulate the formation of a 
larger RP and/or favor SV recycling (Li et al., 2008). This is likely 
to be attributed to increased ATP release from mitochondria since, 
at least at the squid giant synapse, the positive effects of Bcl-xL 
overexpression on neurotransmission can be mimicked by ATP 
injection (Jonas et al., 2003).
That mitochondrial energy production is required for the mobi-
lization of SVs is also supported by numerous studies investigating 
the spatial organization of presynaptic mitochondria and SVs. In 
the cat calyx of Held presynaptic mitochondria are positioned about 
200 nm away from the plasma membrane, next to the active zones, 
within a characteristic structure named mitochondrion-associated 
adherens complex (MAC) (Rowland et al., 2000). Compared to 
other mitochondria in the same neuron, MAC mitochondria dis-
play a higher density of crista-membranes, suggesting increased 
metabolic activity (Perkins et al., 2010). Strikingly, dense popu-
lations of SVs are connected to cytoskeletal elements emanating 
from MACs, which appear to form a barrier between vesicle pools 
associated with neighboring active zones (Perkins et al., 2010). As 
suggested by the authors, this physical separation might contrib-
ute to the different vesicle release probability observed between 
different active zones. At the calyx of Held from rat, presynap-
tic mitochondria are located within so-called “swellings”, where 
they are surrounded by active zones and a large population of SVs 
thought to represent the RP (Wimmer et al., 2006). In both types 
of calyces, this particular distribution of mitochondria relative to 
synaptic vesicles might contribute to trap ATP and glutamate – 
which is generated in mitochondria from precursors emanating 
from the Krebs cycle or from glutamine produced by glial cells 
(Figure 1) – in restricted areas, thereby facilitating vesicle refilling 
and mobilization, ensuring sustained synaptic transmission during 
intense neuronal activity.
In conclusion, although most processes involved in the SV cycle 
are known to be ATP-dependent, experimental evidence point to 
a critical role of mitochondrial ATP production mostly in the 
establishment of large SV pools and in sustained neurotransmit-
ter release during intense neuronal activity, i.e., for mobilization 
of RP vesicles and for vesicle recycling via endocytosis. In contrast, 
where dynamic mitochondria distribution in neurons is adjusted to 
meet the energy requirement for proper neuronal communication. 
Several studies now start to shed light on the exact nature of the 
presynaptic events that most critically depend on mitochondrial 
ATP production.
At Drosophila NMJ synapses, SVs can be assigned to differ-
ent, but spatially mixed functional vesicle pools, the ECP and RP 
(Kuromi and Kidokoro, 2005). Several mutants have been used to 
examine how these two vesicles pools are affected by mitochondrial 
dysfunction. The first observation that was made is that synap-
tic communication is rapidly inhibited when the activity of the 
mitochondrial ATP translocase is switched off by means of the 
thermosensitive mutation sesB (stress sensitive B), suggesting that 
the cytosolic pool of ATP at synaptic terminals is turned over rap-
idly under basal conditions (Rikhy et al., 2003; Trotta et al., 2004), 
at least at high temperature. Further studies showed that these 
mutants have problems maintaining SV cycling during periods of 
high demand. Vesicle trafficking defects are also observed when 
mitochondrial morphology is altered due to impaired fission in 
thermosensitive drp1 mutant flies (Rikhy et al., 2007). Together, 
these observations suggest that mitochondria extensively control 
neuronal function, maybe by influencing SV pools. Because both 
the sesB and drp1 mutations enhance the phenotype of the para-
lytic mutant shibire, where endocytosis is known to be blocked 
at the restrictive temperature (Hinshaw and Schmid, 1995), one 
possibility proposed by the authors is that reduced ATP levels could 
affect endocytosis, thereby preventing efficient SV recycling (Rikhy 
et al., 2003, 2007).
Remarkably, in the absence of presynaptic mitochondria in drp1 
or miro (mitochondrial Rho-GTPase) loss-of-function mutant flies 
basal synaptic activity at the Drosophila neuromuscular junction 
(NMJ) appears not to be significantly altered. In these flies mito-
chondrial fission or axonal mitochondrial transport are inhibited, 
respectively, resulting in synapses largely devoid of mitochondria 
(Guo et al., 2005; Verstreken et al., 2005). In contrast, these mutants 
show impaired neurotransmission during tetanic stimulation (Guo 
et al., 2005; Verstreken et al., 2005) and this phenotype can be 
largely restored by supplementing synapses with exogenous ATP 
(Verstreken et al., 2005), suggesting that energy production by 
presynaptic mitochondria is essential only during intense neuro-
nal activity. Failure of the drp1 mutant to sustain neuronal activity 
during intense stimulation is due to a defect in RP mobilization, 
while basal exocytosis and endocytosis of ECP vesicles is unaffected 
(Verstreken et al., 2005). Similar effects on RP vesicle mobilization 
are observed at wild-type NMJs treated with oligomycin, an inhibi-
tor of the mitochondrial ATP synthase (Figure 1), and forward-
filling drp1 motor neurons with ATP restores the vesicle trafficking 
defects in the RP (Verstreken et al., 2005). Thus, mitochondrial 
ATP production is specifically required for mobilization of the RP, 
a process believed to underlie PTP (Kuromi and Kidokoro, 2005). 
In particular, ATP appears to be needed for RP vesicle propulsion 
along actin filaments mediated by the myosin ATPase complex 
(Verstreken et al., 2005). An additional role of ATP in RP mobiliza-
tion is exerted after its conversion into cAMP by phosphodiesterase 
and adenylate cyclase. cAMP indeed activates the PKA kinase, which 
mediates unthetering of RP vesicles and allows their subsequent 
recruitment at the active zone (Kuromi and Kidokoro, 2005). A very Frontiers in Synaptic Neuroscience  www.frontiersin.org  September 2010  | Volume 2  | Article 139  |  7
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weakness of the muscles followed by muscular atrophy (Zuchner 
et al., 2004). Mutations in OPA1 cause autosomal dominant optic 
atrophy (DOA), characterized by a degeneration of retinal ganglia 
cells leading to optic nerve atrophy (Alexander et al., 2000; Delettre 
et al., 2000). At first sight it might seem that mutations in two 
genes encoding proteins involved in mitochondrial fusion cause 
two diseases with differential phenotypes. Yet CMT2A patients 
have been described to suffer from optic atrophy (Banchs et al., 
2008). Likewise, some DOA patients express additional symptoms 
including peripheral motor-sensory neuropathy (Amati-Bonneau 
et al., 2008). Linking these mitochondrial fusion related diseases 
to defects in neuronal function, the reduced ATP levels as a conse-
quence of less mitochondrial fusion may be responsible for defects 
in SV release and/or recycling under intense stimulation. Taken 
together, these data support the hypothesis that ATP production 
may play a critical role in neuronal communication during intense 
stimulation and that mitochondria play a specific role in regulat-
ing synaptic strength, suggesting that neurological disorders with 
defects in presynaptic mitochondrial function or mitochondrial 
transport also display abnormalities in the SV cycle.
One puzzling feature common to all the diseases discussed here 
is the selective tissue vulnerability associated with mitochondrial 
defects. First of all, the particular mode of mitochondrial inherit-
ance might contribute to the appearance of clinical manifestations 
only in a specific cell population, since stochastic distribution of 
mitochondria between daughter cells can lead to very different 
ratio of mutant to wild-type organelles after cytokinesis (Chan, 
2006). Such a genetic drift has indeed been observed for some 
mitochondrial encephalomyopathies where mitochondrial DNA 
carrying the causative mutation accumulates in a specific region 
of the brain (Kurenai et al., 2000; Betts et al., 2006), although the 
underlying mechanisms remains unknown.
Moreover, compared to other cell types neurons appear par-
ticularly susceptible to mitochondrial dysfunction. This is most 
likely related to their very high energy demands and their spe-
cific  architecture,  as  mitochondria  must  travel  long  distances 
from the cell body to reach regions of intense ATP consumption 
like the presynaptic sites. Defective mitochondrial fusion and/or 
  fission – and hence altered mitochondria recruitment at the nerve 
  terminals – is thus particularly detrimental for these cells (Guo 
et al., 2005; Verstreken et al., 2005). This is expected to be even 
more critical for neurons possessing a very long axon, like those 
innervating distal muscles that are affected in patients with CMT 
disease (Misko et al., 2010).
Finally, in addition to this cellular context the tissue context 
might also influence the sensitivity of some neurons to mitochon-
drial dysfunction. For example, dopaminergic neurons which are 
progressively lost in PD are innervated by glutamatergic neurons, 
likely making them more susceptible to glutamate excitotoxicity 
and hence to calcium overload (Caudle and Zhang, 2009). A defect 
in mitochondrial calcium handling capacity and/or bioenergetics 
would in this model predispose dopaminergic neurons to excito-
toxic damage and be particularly detrimental for them compared 
to other cell types (Greene and Greenamyre, 1996; Nicholls et al., 
2007). We thus surmise that dysfunction or degeneration of spe-
cific neuronal populations in specific neurological diseases may 
be a consequence of both cell autonomous effects that inherently 
low ATP levels produced by glycolysis in the cytosol appear to be 
sufficient to fuel other steps of the SV cycle (Calupca et al., 2001), 
and this is likely accomplished by optimal positioning of glycolytic 
enzymes close to the ATP consumption sites (Ishida et al., 2009).
mItochondrIa and dIsease
As described above, energy generation by mitochondria is of major 
importance for the SV cycle in neurons, and one can expect that 
disturbed ATP production may have deleterious consequences for 
neurons in health and disease. Defects in most of the complexes 
of the ETC (Figure 1) are indeed associated with different neuro-
degenerative diseases and numerous mutations in mitochondrial-
associated proteins have been linked to a variety of neurological 
diseases (Ly and Verstreken, 2006).
One of the best known examples of this is Parkinsonism. The 
first evidence that mitochondria are involved in Parkinson’s dis-
ease (PD) came from the observation that mitochondrial drugs 
like MPTP and rotenone that specifically affect complex I of the 
ETC (Figure 1) cause PD-like symptoms, including degeneration 
of dopaminergic neurons (German et al., 1989; Betarbet et al., 
2000; Panov et al., 2005). It was later shown that mutations in 
the Parkinson related gene pink1 similarly lead to a reduced com-
plex I activity (Gautier et al., 2008; Morais et al., 2009). The prod-
uct of two other Parkinson related genes, parkin and DJ-1, also 
appear to be involved in the regulation of mitochondrial func-
tions (Bonifati et al., 2003; Hayashi et al., 2009a; Wild and Dikic, 
2010). Furthermore, amyotrophic lateral sclerosis (ALS), Leigh’s 
syndrome and multiple sclerosis can also be caused by defects in 
several complexes of the ETC (Kalman et al., 2007; Petrozzi et al., 
2007; Finsterer, 2008).
Aside from direct ETC dysfunction that leads to reduced ATP 
production, disturbed mitochondrial transport to sites of high 
energy demand, including synapses, may also lead to local ATP 
depletion and thus synaptic transmission deficits. As discussed 
before, DRP1, a regulator of mitochondrial fission appears to be a 
key regulatory switch controlling mitochondrial transport and thus 
synaptic ATP production, possibly in response to calcium influx and 
neuronal activity (Lee et al., 2004; Verstreken et al., 2005; Cereghetti 
et al., 2008). While to date no inherited disease resulting directly 
from mutations in genes regulating fission are known; increased 
levels of DRP1, and thus presumably also increased mitochondrial 
fission and synaptic transport has been implicated in alleviating 
Parkinson disease-like phenotypes in flies, yet it is still unclear 
whether these effects are direct or not (Morais et al., 2009; Poole 
et al., 2010). Indeed, increased DRP1 activity is predicted to aug-
ment synaptic ATP production by concentrating mitochondria at 
active synapses, in turn facilitating SV mobilization.
The converse process, mitochondrial fusion, results in lower 
mitochondrial membrane potential and thus reduced ATP produc-
tion (Chen and Chan, 2005) and is associated with neurodegenera-
tion. Three proteins are required for mitochondrial fusion: OPA1, 
mitofusin 1 (Mfn1) and mitofusin 2 (Mfn2) (Chen and Chan, 
2005). The latter two proteins are also required for axonal transport 
of mitochondria (Misko et al., 2010). MFN2 has been identified as 
one of the genes causing Charcot-Marie-Tooth type 2A (CMT2A) 
syndrome. CMT2A is a neuropathy that affects sensory and motor 
neurons of the distal extremities and is characterized by progressive Frontiers in Synaptic Neuroscience  www.frontiersin.org  September 2010  | Volume 2  | Article 139  |  8
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